The Food and Drug Administration inspected American Red Cross Blood Services in Liverpool on March 24 for blood and blood products, according to data posted on the FDA’s website.
The inspection’s final report found that American Red Cross Blood Services did not require any corrective action regarding its management operations.
The FDA regularly inspects facilities nationwide to confirm that workplaces and products comply with its regulations, which are intended to support public health. Results from these inspections are made available to the public.
According to its website, the FDA is a federal agency charged with overseeing the safety and quality of human and animal drugs, biological products, medical devices, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
